Rubi, Spain

Josep Mas-Prió

This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Del Dr. Esteve S.a.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josep Mas-Prió. Retrieved from https://idiyas.com/inventor/josep-mas-priandoacute

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Josep Mas-Prió

Introduction

Josep Mas-Prió is a notable inventor based in Rubi, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antipsychotic compounds. His work has the potential to impact the treatment of psychoses and cognitive deficits.

Latest Patents

Josep Mas-Prió holds a patent for the compound 4-(4-Chlorophenyl)-1,2,3,6-tetrahydro-1-[4-(1H-1,2,4-triazol-1-yl)butyl]pyridine and its physiologically acceptable salts. This antipsychotic compound is designed to treat diseases such as psychosis and dementias characterized by cognitive deficits. The patent outlines pharmaceutical compositions containing this compound and methods for administering a therapeutically effective amount to patients in need.

Career Highlights

Mas-Prió is associated with Laboratorios del Dr. Esteve S.A., where he has been instrumental in advancing pharmaceutical research. His innovative approach to drug development has garnered attention in the scientific community.

Collaborations

He has collaborated with notable colleagues such as Ramon Merce-Vidal and Jordi Frigola-Constansa, contributing to a dynamic research environment that fosters innovation.

Conclusion

Josep Mas-Prió's work exemplifies the intersection of innovation and healthcare, particularly in the realm of psychiatric treatment. His contributions are paving the way for advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…